<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02084615</url>
  </required_header>
  <id_info>
    <org_study_id>2013-0976</org_study_id>
    <nct_id>NCT02084615</nct_id>
  </id_info>
  <brief_title>Prospective Study Investigating Aspirin and Intraoperative Blood Loss and Complications Following Inguinal Hernia Repair</brief_title>
  <official_title>A Prospective, Nonrandomized, Study Comparing the Use of Aspirin and Intraoperative Blood Loss and Postoperative Complications Following Open Inguinal Hernia Repair.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jesse Brown VA Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jesse Brown VA Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether aspirin taken in the perioperative period
      will increase the blood loss associated with open inguinal hernia repairs. A secondary
      purpose of this study is to determine if the aspirin administered in the perioperative period
      increases the risk of complications associated with open inguinal hernia repairs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, non-randomized, study which compares the use of 81mg of aspirin, 325mg
      of aspirin or no aspirin in adult men undergoing an open tension free mesh inguinal hernia
      repair. Subjects currently taking 81mg or 325mg of aspirin will undergo inguinal hernia
      repair without having their medications stopped. Patient not currently taking aspirin will
      act as controls. Intraoperative blood loss will be measured utilizing a gravimetric method by
      weighing surgical sponges before and after use. Subjects will be followed for thirty days
      postoperatively and be evaluated for bleeding complications. The specific complications
      include wound or scrotal hematomas, return to the operating room within 72 hour for bleeding,
      wound infection, early recurrent hernia, excessive wound ecchymosis.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>August 2014</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intraoperative blood loss</measure>
    <time_frame>intraoperative only</time_frame>
    <description>intraoperative blood loss will be accurately measured among the three arms of the study</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Serious and Non-Serious Adverse Events</measure>
    <time_frame>30 days post operative</time_frame>
    <description>Subjects will be followed for 30 days post-operatively for bleeding complications such as early return to the operating room to control bleeding, wound hematoma, scrotal hematoma, wound infection, early hernia recurrence, or excessive wound ecchymosis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Hernia, Inguinal</condition>
  <condition>Postoperative Complications</condition>
  <condition>Postoperative Hemorrhage</condition>
  <arm_group>
    <arm_group_label>81mg aspirin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm will include perioperative 81 mg of aspirin.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>325mg aspirin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be taking 325mg of aspirin.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aspirin</intervention_name>
    <description>Subjects will undergo open inguinal hernia repairs while taking their normal dose of 81mg, 325mg, or no aspirin</description>
    <arm_group_label>81mg aspirin</arm_group_label>
    <arm_group_label>325mg aspirin</arm_group_label>
    <other_name>acetylsalicylic acid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult male veterans ages 18-99

          -  inguinal hernia

          -  subjects currently taking 81mg, 325mg or no aspirin

        Exclusion Criteria:

          -  recurrent hernia

          -  &quot;giant&quot; hernia

          -  women

          -  International Normalized Ratio &gt; 1.7

          -  Hemophilia or other know congenital bleeding disorder

          -  Cirrhosis of hepatitis with coagulopathy

          -  Thrombocytopenia with platelet counts &lt; 100,000

          -  Subjects currently on Coumadin or other platelet inhibitors
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph M Vitello, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jesse Brown VA Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jesse Brown VA Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Antolovic D, Rakow A, Contin P, Ulrich A, Rahbari NN, Büchler MW, Weitz J, Koch M. A randomised controlled pilot trial to evaluate and optimize the use of anti-platelet agents in the perioperative management in patients undergoing general and abdominal surgery--the APAP trial (ISRCTN45810007). Langenbecks Arch Surg. 2012 Feb;397(2):297-306. doi: 10.1007/s00423-011-0867-7. Epub 2011 Nov 3.</citation>
    <PMID>22048442</PMID>
  </reference>
  <reference>
    <citation>Binhas M, Salomon L, Roudot-Thoraval F, Armand C, Plaud B, Marty J. Radical prostatectomy with robot-assisted radical prostatectomy and laparoscopic radical prostatectomy under low-dose aspirin does not significantly increase blood loss. Urology. 2012 Mar;79(3):591-5. doi: 10.1016/j.urology.2011.11.031.</citation>
    <PMID>22386405</PMID>
  </reference>
  <reference>
    <citation>Burger W, Chemnitius JM, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med. 2005 May;257(5):399-414. Review.</citation>
    <PMID>15836656</PMID>
  </reference>
  <reference>
    <citation>Chechik O, Goldstein Y, Behrbalk E, Kaufman E, Rabinovich Y. Blood loss and complications following carotid endarterectomy in patients treated with clopidogrel. Vascular. 2012 Aug;20(4):193-7. doi: 10.1258/vasc.2011.oa0336. Epub 2012 May 10.</citation>
    <PMID>22577162</PMID>
  </reference>
  <reference>
    <citation>Gerstein NS, Schulman PM, Gerstein WH, Petersen TR, Tawil I. Should more patients continue aspirin therapy perioperatively?: clinical impact of aspirin withdrawal syndrome. Ann Surg. 2012 May;255(5):811-9. doi: 10.1097/SLA.0b013e318250504e. Review.</citation>
    <PMID>22470078</PMID>
  </reference>
  <reference>
    <citation>Kang SB, Cho KJ, Moon KH, Jung JH, Jung SJ. Does low-dose aspirin increase blood loss after spinal fusion surgery? Spine J. 2011 Apr;11(4):303-7. doi: 10.1016/j.spinee.2011.02.006.</citation>
    <PMID>21474081</PMID>
  </reference>
  <reference>
    <citation>Leyh-Bannurah SR, Hansen J, Isbarn H, Steuber T, Tennstedt P, Michl U, Schlomm T, Haese A, Heinzer H, Huland H, Graefen M, Budäus L. Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm? BJU Int. 2014 Sep;114(3):396-403. doi: 10.1111/bju.12504. Epub 2014 Jul 15. Review.</citation>
    <PMID>24127902</PMID>
  </reference>
  <reference>
    <citation>Madan GA, Madan SG, Madan G, Madan AD. Minor oral surgery without stopping daily low-dose aspirin therapy: a study of 51 patients. J Oral Maxillofac Surg. 2005 Sep;63(9):1262-5.</citation>
    <PMID>16122588</PMID>
  </reference>
  <reference>
    <citation>Manning BJ, O'Brien N, Aravindan S, Cahill RA, McGreal G, Redmond HP. The effect of aspirin on blood loss and transfusion requirements in patients with femoral neck fractures. Injury. 2004 Feb;35(2):121-4.</citation>
    <PMID>14736467</PMID>
  </reference>
  <reference>
    <citation>Ono K, Idani H, Hidaka H, Kusudo K, Koyama Y, Taguchi S. Effect of aspirin continuation on blood loss and postoperative morbidity in patients undergoing laparoscopic cholecystectomy or colorectal cancer resection. Surg Laparosc Endosc Percutan Tech. 2013 Feb;23(1):97-100. doi: 10.1097/SLE.0b013e318278cdf8.</citation>
    <PMID>23386161</PMID>
  </reference>
  <reference>
    <citation>Oscarsson A, Gupta A, Fredrikson M, Järhult J, Nyström M, Pettersson E, Darvish B, Krook H, Swahn E, Eintrei C. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth. 2010 Mar;104(3):305-12. doi: 10.1093/bja/aeq003.</citation>
    <PMID>20150346</PMID>
  </reference>
  <reference>
    <citation>Partridge CG, Campbell JH, Alvarado F. The effect of platelet-altering medications on bleeding from minor oral surgery procedures. J Oral Maxillofac Surg. 2008 Jan;66(1):93-7.</citation>
    <PMID>18083421</PMID>
  </reference>
  <reference>
    <citation>Zigdon H, Levin L, Filatov M, Oettinger-Barak O, Machtei EE. Intraoperative bleeding during open flap debridement and regenerative periodontal surgery. J Periodontol. 2012 Jan;83(1):55-60. doi: 10.1902/jop.2011.110182. Epub 2011 May 12.</citation>
    <PMID>21563946</PMID>
  </reference>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2014</study_first_submitted>
  <study_first_submitted_qc>March 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 12, 2014</study_first_posted>
  <last_update_submitted>June 16, 2015</last_update_submitted>
  <last_update_submitted_qc>June 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jesse Brown VA Medical Center</investigator_affiliation>
    <investigator_full_name>Joseph Vitello, MD</investigator_full_name>
    <investigator_title>Interim Chief of Surgical Services</investigator_title>
  </responsible_party>
  <keyword>Aspirin</keyword>
  <keyword>Postoperative hemorrhage</keyword>
  <keyword>Inguinal hernia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
    <mesh_term>Postoperative Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

